Causes of death during tuberculosis treatment in Tomsk Oblast, Russia

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 8, 2006, Pages 857-863

  Mathew, Trini A ^a,b,g   Ovsyanikova, T N ^c   Shin, S S ^a   Gelmanova, I ^d   Balbuena, D A ^a   Atwood, S ^a,e   Peremitin, G G ^c   Strelis, A K ^f   Murray, M B ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Tomsk Oblast Tuberculosis Services   (Russian Federation)

^d PARTNERS IN HEALTH   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^g NONE   (United States)

Author keywords

Mortality; Russia; Tomsk, Siberia; Tuberculosis

Indexed keywords

ADULT; AGED; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MALE; MORTALITY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; RUSSIAN FEDERATION; TUBERCULOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CAUSE OF DEATH; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SIBERIA; SURVIVAL ANALYSIS; TIME FACTORS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 33746918719     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. World Health Organization. Global Tuberculosis Control report 1998. WHO/TB/98.237. Geneva, Switzerland: WHO, 1998.
2. World Health Organization. WHO Report 2006: Global tuberculosis control-surveillance, planning, financing. WHO/HTM/ TB/2006.362. Geneva, Switzerland: WHO, 2006. http://www. who.int/tb/publications/global_report/2006/ download_centre/ en/index.html
3. Farmer P, Kononets A, Borisov S, Goldfarb A, Healing T. Recrudescent tuberculosis in the Russian Federation. In: Farmer P, Becerra M, Kim J Y, eds. The global impact of drug resistant tuberculosis. Boston, Massachusetts, USA: Harvard Medical School, 1999: pp 39-83.
4. Men T, Brennan P, Boffetta P, Zaridze D. Russian mortality trends for 1991-2001: analysis by cause and region. BMJ 2003; 327: 964.
5. Toungoussova O S, Nizovtseva N I, Mariandyshev A O, Caugant D A, Sandven P, Bjune G. Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel oblast, Russia, in 1999. Eur J Clin Microbiol Infect Dis 2004; 23: 174-179.
6. Malyutina S, Bobak M, Kurilovitch S, Nikitin Y, Marmot M. Trends in alcohol intake by education and marital status in urban population in Russia between the mid 1980s and the mid 1990s. Alcohol 2004; 39: 64-69.
7. Dewan P K, Arguin P M, Kiryanova H, et al. Risk factors for death during tuberculosis treatment in Orel, Russia. Int J Tuberc Lung Dis 2004; 8: 598-602.
8. Osborn A. Russia's youth faces worst crisis of homelessness and substance misuse since second world war. BMJ 2005; 330: 1348.
9. Shilova M V. Specific features of the spread of tuberculosis in Russia at the end of the 20th century. Ann N Y Acad Sci 2001; 953: 124-132.
10. Atun R A, Samyshkin Y A, Drobniewski F, et al. Barriers to sustainable tuberculosis control in the Russian Federation health system. Bull World Health Organ 2005; 83: 217-223.
11. Danishevski K, McKee M. Reforming the Russian health-care system. Lancet 2005; 365: 1012-1014.
12. Ellman M. The increase in death and disease under 'katstroika'. Cambridge J Econ 1994; 18: 329-355.
13. Aris B. Russia's health crisis fuels 20-year cut in lifespan estimates. [see comment]. Lancet 2003; 362: 1557.
14. Plavinski S L, Plavinskaya S I, Klimov A N. Social factors and increase in mortality in Russia in the 1990s: prospective cohort study. BMJ 2003; 326: 1240-1242.
15. Walberg P, McKee M, Shkolnikov V, Chenet L, Leon D A. Economic change, crime, and mortality crisis in Russia: regional analysis. BMJ 1998; 317: 312-318.
16. TB incidence, prevalence, and mortality in Tomsk Oblast civilian sector, 1998-2003. Tomsk, Russian Federation: Tomsk Oblast Tuberculosis Services, 2005.
17. World Health Organization/International Union Against Tuberculosis and Lung Disease. Global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world. Report no. 2, prevalence and trends. WHO/CDS/ TB/2000.278. Geneva, Switzerland: WHO, 2000.
18. WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world: third global report. Geneva, Switzerland: WHO, 2004.
19. World Health Organization. TB manual: national tuberculosis programme guidelines. Geneva, Switzerland: WHO, 2004.
20. http://www.euro.who.int/document/e75464.pdf Accessed May 2006.
21. Farmer P, Kim J Y. Community based approaches to the control of multidrug resistant tuberculosis: introducing 'DOTS-Plus'. BMJ 1998; 317: 671-674.
22. Last J. A dictionary of epidemiology. Oxford, UK: Oxford University Press, 2001.
23. Leon D, Chenet L, Shkoolnikov V, et al. Huge variation in Russian mortality rates 1984-94: artifact, alcohol, or what? Lancet 1997; 350: 383-388.
24. Peto R, Lopez A D, Boreham J, Thun M. Mortality from smoking in developed countries, 1950-2000. Russian Federation. Oxford, UK: Clinical Trial Service Unit, 2005. http://www.ctsu. ox.ac.uk/~tobacco/C4272.pdf Accessed May 2006.
25. Mawer C, Ignatenko N, Wares D, et al. Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia. Lancet 2001; 358: 445-449.
26. Wobeser W, Yuan L, Naus M. Outcome of pulmonary tuberculosis treatment in the tertiary care setting-Toronto 1992/93. Tuberculosis Treatment Completion Study Group. CMAJ 1999; 160: 789-794.
27. Quy H, Cobelens F, Lan N, Buu T, Lambregts C, Borgdorff M. Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2006; 10: 45-51.
28. Helbling P, Medinger C, Altpeter E, Raeber P, Beeli D, Zellweger J. Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996. Swiss Med Wkly 2002; 132: 517-522.
29. Falzon D, Le Strat Y, Belghiti F, Infuso A, EuroTB Correspondents. Exploring the determinants of treatment success for tuberculosis cases in Europe. Int J Tuberc Lung Dis 2005; 9: 1224-1229.
30. Nelson L, Naik Y, Tsering K, Cegielski P. Population-based risk factors for tuberculosis and adverse outcomes among Tibetan refugees in India, 1994-1996. Int J Tuberc Lung Dis 2005; 9: 1018-1026.
31. Farah M, Tverdal A, Steen T, Heldal E, Brantsaeter A, Bjune G. Treatment outcome of new culture-positive pulmonary tuberculosis in Norway. BMC Public Health 2005; 5: 14-20.
32. Tocque K, Convrey R P, Bellis M A, Beeching N J, Davies P D. Elevated mortality following diagnosis with a treatable disease: tuberculosis. Int J Tuberc Lung Dis 2005; 9: 797-802.
33. Takahara M. Clinical evaluation of causes of death in patients with pulmonary tuberculosis. Kekkaku 2004; 79: 711-716.
34. Walpola H C, Siskind V, Patel A M, Konstantinos A, Derhy P. Tuberculosis-related deaths in Queensland, Australia, 1989-1998: characteristics and risk factors. Int J Tuberc Lung Dis 2003; 7: 742-750.
35. Olle-Goig J E. Patients with tuberculosis in Bolivia: why do they die? Rev Panam Salud Publica 2000; 8: 151-155.
36. Moorman J, Edginton M E. Cause of death of patients on treatment for tuberculosis: a study in a rural South African hospital. Int J Tuberc Lung Dis 1999; 3: 786-790.